Enfermedad meningocócica en España (1940-2012). Tendencias de la incidencia y evolución de los serogrupos antes y después de las campañas de vacunación

MD is an important public health problem in Spain. The serogroup C conjugate vaccine has succeeded in controlling meningococcal disease caused by serogroup C. The new vaccines against serogroup B offer the possibility of minimizing the incidence of MD. All this creates a scenario of caution and moderate optimism for this disease, keeping vaccines available for their control.